Exactech Inc. manufactured knee replacement implants with defective packaging that lacked an inner oxygen barrier, causing polyethylene liners to degrade before implantation. The resulting premature implant failures led to a 2022 recall covering ~147,000 US patients. Lawsuits allege Exactech and parent company TPG Capital knew of the packaging defect and failed to warn surgeons and patients. The primary remedy — revision surgery — is a major operation with serious complication risks.
Litigation Timeline
TPG Capital Acquires Exactech for $737 Million
Private equity firm TPG Capital completes acquisition of Exactech Inc., a Gainesville, Florida-based orthopedic implant manufacturer, for approximately $737 million. Plaintiffs allege TPG assumed responsibility for known quality control deficiencies, including the non-conforming packaging used on PE liners, and failed to remediate the defect post-acquisition.
Exactech Initiates Voluntary Recall — Initial Scope
Exactech voluntarily initiates a recall of certain polyethylene knee, hip, and ankle replacement components with the FDA. The recall is classified as Class II (risk of adverse health consequences, though not immediately life-threatening). Initial scope covers select product lines with identified packaging non-conformance — the defective single-barrier vacuum bags lacking the required inner oxygen barrier layer.
Recall Dramatically Expanded to 147,000 US Patients
Exactech dramatically expands the voluntary recall to encompass approximately 147,000 affected devices in the United States. The expanded recall covers Optetrak, Optetrak Logic, and Truliant knee systems, plus Alteon, Novation, and Connexion hip systems and the Vantage ankle system — all PE liners packaged in non-conforming bags. The scale of the expansion triggers widespread media coverage and alerts orthopedic surgeons nationwide to identify and notify affected patients.
First Product Liability Lawsuits Filed Against Exactech and TPG Capital
Plaintiff attorneys begin filing the first wave of product liability lawsuits against Exactech Inc. and TPG Capital in state and federal courts. Initial filings are concentrated in New York state court and the Middle District of Florida. Complaints allege manufacturing defect, design defect, failure to warn, negligence, breach of implied warranty, and fraud or misrepresentation. TPG Capital is named under alter-ego and PE parent liability theories.
Case Concentration and Informal Coordination in State Courts
As the case count exceeds several hundred filings across state and federal courts, plaintiff steering committees begin organizing informal coordination of pretrial proceedings. New York state court (complex litigation part) emerges as the primary venue for coordinated discovery. The Middle District of Florida also sees significant case volume given Exactech's Gainesville headquarters. Discussions of a formal federal MDL petition are ongoing among plaintiff leadership.
Over 1,000 Cases Filed; Bellwether Selection Discussions Begin
The total case count across federal and state courts surpasses 1,000 filed claims as of Q4 2025. Plaintiff and defense counsel begin discussions regarding bellwether trial selection — a representative group of cases selected for early trial to inform the parties on litigation value and factual disputes. Expert discovery, including science days on PE oxidation science and packaging industry standards, is anticipated in 2026. First bellwether trials are projected for 2027 in the absence of a global settlement.
Get free updates on the Exactech Knee Recall as it develops
No phone call required. We will email you when there is meaningful news — new filings, settlements, or important deadlines.
Want the Complete Picture?
View eligibility criteria, settlement information, scientific evidence, and start a free case review.
View Full Exactech Knee Recall Case Page